Drug · DIN 02366010
HALOPERIDOL INJECTION
FOR I.M. INJECTION ONLY. NOT FOR I.V USE. PRESERVATIVE-FREE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 20, 2026; first marketed September 19, 2011.
- Drug Identification Number (DIN)
- 02366010
- Company (DIN owner)
- Juno Pharma Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Haloperidol N05AD01
- Class
- Human
- Record last updated
- August 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HALOPERIDOL | 5 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 20, 2026: NOC 38146Abbreviated New Drug Submission (ANDS) · Administrative: Merger/Buy-out
- March 24, 2011: NOC 12213Abbreviated New Drug Submission (ANDS)
Other DINs named HALOPERIDOL INJECTION
- DIN 02493993 · Cancelled (Unreturned Annual)
- DIN 02540223 · Cancelled Pre Market